M&A activities in the life sciences space are at an all time high. JENLO's experience in the life science sector can clarify the risks associated with a potential transaction. We have extensive experience in assessing compliance, regulatory and quality risks an organization faces and the potential financial impact of those risks on an organization. Often times due diligence can identify an area of concern but are unable to properly quantify the risk. JENLO consultants evaluate every issue through a business lens in order to properly evaluate potential deals.